Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The actomyosin complex is a fundamental molecular machine composed of actin filaments and myosin motor proteins, primarily responsible for converting chemical energy from ATP hydrolysis into mechanical work. In muscle cells, this interaction facilitates the sliding filament mechanism, which is the basis for muscle contraction and force generation. In non-muscle cells, the complex plays critical roles in maintaining cell structure, driving cytokinesis during cell division, and enabling cell migration. The regulation of the actomyosin complex is highly complex, involving calcium signaling, phosphorylation of myosin light chains, and various regulatory proteins like troponin and tropomyosin (Source: UniProt, PubMed). Clinically, the actomyosin complex is a major therapeutic target for cardiovascular diseases. Drugs such as mavacamten act as cardiac myosin inhibitors to treat hypertrophic cardiomyopathy by reducing excessive contractility, while activators like omecamtiv mecarbil are designed to enhance cardiac output in patients with heart failure with reduced ejection fraction (Source: NIH, StatPearls). Beyond cardiology, the complex is studied in oncology for its role in the mechanical changes required for cancer cell invasion and metastasis. Understanding the isoform-specific interactions within the actomyosin complex is essential for developing targeted therapies that minimize systemic side effects (Source: Wikipedia, Peer-reviewed journals).
Modulation of myosin ATPase activity, stabilization of the actin-myosin cross-bridge, or inhibition of the power stroke to alter contractile force.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actomyosin complex (Actomyosin).